Company: CGC
Filing Date: 2025-05-29
Form Type: POSASR
Source: 0001104659-25-054285
Chunk: 42

Company: Canopy Growth Corp
Filing Date: 2025-05-29
Form: POSASR
Chunk 42
---
 the section titled “Risk Factors” in this prospectus supplement, in the Annual Report and in our subsequently filed Quarterly Reports on Form 10-Q, and in the other documents or information included, or incorporated by reference, in this prospectus supplement for a discussion of some of the risks and uncertainties you should carefully consider before deciding to invest in our Common Shares.

#### Market for our Common Shares
Our Common Shares are listed on the TSX under the symbol “WEED” and on the Nasdaq Global Select Market under the symbol “CGC.”

(1)

The number of Common Shares to be outstanding after this offering and the Concurrent Canadian Offering is based on 185,192,210 Common Shares outstanding as of May 28, 2025 and excludes up to 67,041,843 additional Common Shares, as follows:

•

26,261,474 of our Common Shares issuable upon conversion of the issued and outstanding non-voting and non-participating exchangeable shares in the capital of the Company (the “Exchangeable Shares”) (and assumes that no additional Common Shares are converted into Exchangeable Shares during the term of this offering);

•

up to 3,542,716 of our Common Shares issuable upon the exercise of stock options outstanding as of May 28, 2025 under the Canopy Growth Corporation Omnibus Equity Incentive Plan (the “Omnibus Incentive Plan”) at a weighted average exercise price of $22.44 (C$31.08) per Common Share;

•

up to 1,232,415 Common Shares issuable upon the vesting of restricted share units outstanding under the Omnibus Incentive Plan;

•

up to 73,461 Common Shares issuable upon the vesting of performance share units outstanding under the Omnibus Incentive Plan;

•

up to 13,670,629 Common Shares available for future issuance under the Omnibus Incentive Plan, based on the Common Shares outstanding as of May 28, 2025 (the Omnibus Incentive Plan provides

<div align='center'>S-3</div>

TABLE OF CONTENTS

that the aggregate number of Common Shares reserved for issuance for awards granted under the Omnibus Incentive Plan and under all other equity plans of the Company shall not exceed 10% of the Company’s total issued and outstanding Common Shares from time to time);

•

up to 15,483,580 Common Shares issuable upon exercise of common share purchase warrants (“Warrants”) with a weighted average